Cronos Group Inc.
CRON · XNASCIK 1656472fmd_00NAW0GDHWX6N9ZHAG63YWG6AHManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2016 to Sep 30, 2026, 37 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 3 | 12 | 24 | 47 | 65 | 87 | 87 | 118 | 147 |
| Gross profit | 2 | 6 | (18) | (26) | (18) | 15 | 12 | 25 | 63 |
| Provision for credit losses | – | 0 | 0 | 2 | 12 | (1) | (2) | (11) | 5 |
| Realized investment gains (losses) | – | – | – | (5) | 2 | 18 | (11) | (4) | (0) |
| Research and development | 0 | 2 | 12 | 20 | 22 | 13 | 6 | 4 | 4 |
| Selling, general and administrative | 5 | 16 | 105 | 115 | 112 | 86 | 72 | 68 | 64 |
| Compensation and benefits | 1 | 4 | 18 | 27 | – | – | – | – | – |
| Total operating expenses | 8 | 27 | 136 | 194 | 274 | 127 | 97 | 102 | 80 |
| Operating income | (6) | (20) | (153) | (219) | (292) | (111) | (85) | (77) | (17) |
| Interest expense | 0 | 0 | 1 | 0 | 0 | 0 | – | – | – |
| Interest and investment income | 0 | 0 | 29 | 19 | 9 | 23 | – | – | – |
| Other non-operating income (expense) | 4 | (0) | 1,319 | 146 | 163 | (10) | 11 | 113 | 0 |
| Income before taxes | (2) | (21) | 1,166 | (73) | (129) | (121) | (74) | 37 | (17) |
| Income tax expense | (1) | 0 | 0 | 1 | (0) | 34 | (3) | (3) | (14) |
| Net income from continuing operations | (1) | (21) | 1,166 | (75) | (128) | (155) | (70) | 40 | (3) |
| Net income | (1) | (22) | 1,167 | (73) | (396) | (169) | (74) | 41 | (9) |
| Net income to common shareholders | (1) | (21) | 1,167 | (72) | – | – | – | – | – |